Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive and Prognostic Significance of Molecular Biomarkers in Glioblastoma

22 Nov 2024

Abstract excerpt

Glioblastoma multiforme (GBM), a WHO grade 4 glioma, is the most common and aggressive primary brain tumor, characterized by rapid progression and poor prognosis. The heterogeneity of GBM complicates diagnosis and treatment, driving research into molecular biomarkers that can offer insights into tumor behavior and guide personalized therapies. This review explores recent advances in molecular biomarkers,...

Topics

Join the communities discussing this publication.

Ferroptosis and cancer prognosis
Glioma Diagnosis and Treatment
MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39767571
DOI: 10.3390/biomedicines12122664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive and Prognostic Significance of Molecular Biomarkers in GlioblastomaPMID 39767571Read ↗

Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Semantic proximity Read ↗

A practical review of prognostic correlations of molecular biomarkers in glioblastomaSemantic proximity Read ↗

Prognostic and Predictive Biomarkers in Gliomas.Semantic proximity Read ↗

Glioblastoma: An Update in Pathology, Molecular Mechanisms and BiomarkersSemantic proximity Read ↗

Clinical impact of molecular biomarkers in gliomas.Semantic proximity Read ↗

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Biomarkers and therapeutic advances in glioblastoma multiformeSemantic proximity Read ↗

Predictive biomarkers investigated in glioblastomaSemantic proximity Read ↗

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesSemantic proximity Read ↗

Molecular pathology in adult high‐grade gliomas: from molecular diagnostics to target therapiesSemantic proximity Read ↗

The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations.Semantic proximity Read ↗

Genomic, epigenomic and transcriptomic landscape of glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.